Urgent Call to Action: African Ministers Demand Accelerated Malaria Fight as Vaccine Rollout Gains Momentum
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Urgent Call to Action: African Ministers Demand Accelerated Malaria Fight as Vaccine Rollout Gains Momentum
-
ナレーター：
-
著者：
このコンテンツについて
One of the key topics of discussion was the ongoing rollout and scale-up of malaria vaccines. By July 2025, close to six million children had received a malaria vaccine in 20 countries, marking a major step forward in prevention. The introduction of this vaccine is widely viewed as a game changer, complementing other interventions such as insecticide-treated bed nets and seasonal malaria chemoprevention. WHO Regional Director for Africa Dr Mohamed Janabi emphasized the urgency of ramping up coverage, stating that ending malaria would not only save lives but also drive economic growth and stability.
Efforts to boost Africa’s capacity for vaccine research, development, and production received a boost this week with a new Memorandum of Understanding signed between WHO Africa and the International Vaccine Institute. As reported by the WHO, this new partnership aims to increase vaccine equity, support local manufacturing, and strengthen health innovation across the continent. Dr Jerome Kim, Director General of the International Vaccine Institute, noted that the agreement marks a new phase of leadership in vaccine innovation, including for malaria vaccines. The collaboration is expected to facilitate technology transfer, harmonize regulatory standards, and build regional expertise in vaccinology and biomanufacturing.
Research groups such as Target Malaria have reaffirmed their commitment to developing innovative interventions against malaria, including genetic technologies to modify mosquitoes and reduce transmission. In a public statement released August 28, Target Malaria stressed the need for integrating new tools alongside vaccines, and highlighted the importance of responsible, community-engaged research tailored to Africa’s context. The group receives significant support from institutions such as the Gates Foundation and partners across Africa and Europe.
Despite these scientific advances, malaria control faces looming challenges from global funding shortfalls. According to Think Global Health, this year’s global funding for malaria and other infectious disease control is under strain, with Gavi, the Vaccine Alliance, and other organizations facing cuts due to major donors including the United States pulling back support. The Global Fund to Fight AIDS, Tuberculosis and Malaria will seek $18 billion at its upcoming replenishment conference but donor fatigue and shifting international priorities pose risks to sustained progress, especially in sub-Saharan Africa where the disease burden remains highest.
Amid these mixed signals, health leaders stressed that continued investment and coordinated action are vital, especially as some countries show what is possible: Algeria in 2019 and Cabo Verde in 2024 were both certified malaria-free, and Rwanda and Sao Tome and Principe are on track to hit 2025 targets. The consensus from experts and policymakers alike is clear—malaria can be consigned to history, but only if the momentum on vaccines, research, and funding is not just maintained, but intensified.
まだレビューはありません